BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/8/2022 12:06:55 PM | Browse: 309 | Download: 1073
 |
Received |
|
2021-03-19 02:02 |
|
Peer-Review Started |
|
2021-03-19 02:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-08 00:41 |
|
Revised |
|
2021-05-10 23:32 |
|
Second Decision |
|
2021-05-25 08:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-25 11:32 |
|
Articles in Press |
|
2021-05-25 11:32 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-03-06 03:07 |
|
Typeset the Manuscript |
|
2022-03-24 06:56 |
|
Publish the Manuscript Online |
|
2022-04-08 12:06 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Min Yao, Jun-Ling Yang, De-Feng Wang, Li Wang, Ying Chen and Deng-Fu Yao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Nantong S&T Development Plan |
MS12020021 |
| National Natural Science Foundation of China |
81673241 |
| National Natural Science Foundation of China |
31872738 |
| Nantong S&T Development Plan |
MS12019016 |
|
| Corresponding Author |
Deng-Fu Yao, MD, PhD, Director, Director, Full Professor, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, No. 20 West Temple Road, Nantong 226001, Jiangsu Province, China. yaodf@ahnmc.com |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Carcinoembryonic proteins; Specific biomarkers; Wnt/β-catenin pathway; Signal molecules |
| Core Tip |
Tissues in hepatocellular carcinoma (HCC) or hepatocyte malignant transformation can express and secrete a variety of molecules with specific biomarkers or oncogenic antigens into blood. These biomarkers not only contribute to the diagnosis and prognosis of HCC, they but also might become the molecular-targets for HCC treatment under developing or clinical trials. This article reviews the recent progress of some emerging biomarkers in basic researches or clinical trials for HCC immunotherapy. |
| Publish Date |
2022-04-08 12:06 |
| Citation |
Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i11/3321.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i11.3321 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
